Hyderabad, India-based Bharat Biotech, announced a partnership with Spanish biopharmaceutical company BioFabri to develop, manufacture and distribute a new tuberculosis vaccine. MTBVAC, a live attenuated vaccine, is considered one of the most promising vaccine candidates in the current global TB vaccine pipeline. Biofabri is part of the Zendal Group based in...
India Approves Nasal Covid-19 Vaccine
The Drug Controller General of India authorized the country’s first nasal spray vaccine "under Restricted Use in Emergency Situations for ages 18 and above," marking a big step toward increasing the availability of needle-free vaccines around the world. Washington University St. Louis, which had created and developed the recombinant adenoviral...